Logo-jrip
J Renal Inj Prev. 2022;11(2): e31969. doi: 10.34172/jrip.2022.31969

Mini-Review

Benefits and risks of dual inhibition of the renin– angiotensin aldosterone system for kidney disease

Nader Nourimajalan 1 * ORCID, Ahmad Shajari 2 ORCID, Sarasadat Moghadasimousavi 3

Cited by CrossRef: 0